Morning Market Movers

MannKind

surged 95.77% to $7.87 after the company confirmed that the FDA Advisory Committee recommended the approval of the company's diabetes drug AFREZZA. Acceleron Pharma

shares gained 20.43% to $40.79 after Form 8-K for Acceleron Pharma showed that Celgene

will buy 1.1 million shares for $47.15 million. Envivio

shares jumped 18.18% to $3.90 after the company reported that it was powering live HD sports channels on Apple TV in Europe. Alliance Fiber Optic Products

gained 15.45% to $17.11 after the company issued a strong Q1 forecast. Myriad Genetics

gained 12.48% to $39.53 after the Centers for Medicare & Medicaid Services updated pricing for the sequencing of the BRCA1 and BRCA2 genes. Tetraphase Pharmaceuticals

surged 10.35% to $12.47 after the US FDA awarded the Fast Track status to Tetraphase Pharmaceuticals for the intravenous and oral formulations of eravacycline. CryoLife

shares climbed 2.82% to $10.60 after the company received the FDA approval to begin trials for Perclot in the US. Intuitive Surgical

climbed 1.67% to $501.83 after climbing 12.70% on Tuesday. JMP Securities upgraded the stock from Market Underperform to Market Outperform and lifted the price target from $320.00 to $700.00. Monsanto Company

shares surged 0.49% to $114.12 after the company announced upbeat FQ2 earnings. Monsanto's quarterly profit surged to $1.67 billion, or $3.15 per share, versus a year-ago profit of $1.48 billion, or $2.74 per share.